Search

Displaying results 7091 - 7100 of 10000 in total
  1. Drug

    CoVac-1

    go.drugbank.com/drugs/DB16429
    Investigational

    Sponsored by the University Hospital Tuebingen in Germany, CoVac-1 is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein[A226588]. … It is being investigated in the clinical trial NCT04546841 (Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults (pVAC))[L30428] and aims to induce broad

  2. Drug

    Ciglitazone

    go.drugbank.com/drugs/DB09201
    Experimental

    Ciglitazone is a potent and selective PPARγ ligand with an EC50 of 3.0 µM. It is also an anti-hyperglycemic agent in the ob/ob murine model in vivo. … Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones.

  3. Drug

    Ravuconazole

    go.drugbank.com/drugs/DB06440
    Investigational

  4. Drug

    Arverapamil

    go.drugbank.com/drugs/DB06669
    Investigational

  5. Drug

    Sotirimod

    go.drugbank.com/drugs/DB05680
    Experimental

  6. Drug

    Naronapride

    go.drugbank.com/drugs/DB05542
    Investigational

  7. Drug

    Casopitant

    go.drugbank.com/drugs/DB06634
    Investigational

  8. Drug

    Basroparib

    go.drugbank.com/drugs/DB21582
    Investigational

    Basroparib is a small molecule drug. The usage of the INN stem '-parib' in the name indicates that Basroparib is a poly-ADP-Ribose polymerase inhibitor. … Basroparib is under investigation in clinical trial NCT04505839 (First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors).

  9. Drug

    Imnopitant

    go.drugbank.com/drugs/DB21456
    Experimental

    Imnopitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Imnopitant is a neurokinin NK1​ (substance P) receptor antagonist. … Imnopitant has a monoisotopic molecular weight of 550.22 Da.

  10. Drug

    Libvatrep

    go.drugbank.com/drugs/DB21488
    Experimental

    Libvatrep is a small molecule drug. The usage of the INN stem '-vatrep' in the name indicates that Libvatrep is a transient receptor potential vanilloid (TRPV) antagonist. … Libvatrep has a monoisotopic molecular weight of 305.12 Da.